Christopher Peetz
Net Worth

Last updated:

What is Christopher Peetz net worth?

The estimated net worth of Mr. Christopher Peetz is at least $12,010,500 as of 2 Feb 2024. He owns shares worth $6,783,938 as insider, has earned $515,242 from insider trading and has received compensation worth at least $4,711,320 in Mirum Pharmaceuticals, Inc..

What is the salary of Christopher Peetz?

Mr. Christopher Peetz salary is $785,220 per year as Pres, Chief Executive Officer & Director in Mirum Pharmaceuticals, Inc..

How old is Christopher Peetz?

Mr. Christopher Peetz is 46 years old, born in 1979.

What stocks does Christopher Peetz currently own?

As insider, Mr. Christopher Peetz owns shares in one company:

Company Title Shares Price per share Total value
Mirum Pharmaceuticals, Inc. (MIRM) Pres, Chief Executive Officer & Director 104,112 $65.16 $6,783,938

What does Mirum Pharmaceuticals, Inc. do?

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.

MIRM logo
MIRM
Mirum Pharmaceuticals, Inc.
$65.16

Christopher Peetz insider trading

Mirum Pharmaceuticals, Inc.

Mr. Christopher Peetz has made 4 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 6,013 units of MIRM stock worth $157,492 on 2 Feb 2024.

The largest trade he's ever made was exercising 7,000 units of MIRM stock on 24 Nov 2021. As of 2 Feb 2024 he still owns at least 104,112 units of MIRM stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 6,013 $26.19 $157,492
Sale
Common Stock 5,209 $28.04 $146,034
Sale
Common Stock 5,498 $25.65 $141,007
Purchase
Common Stock 7,000 $14.4 $100,800
Sale
Common Stock 3,672 $19.26 $70,708
Purchase
Common Stock 5,000 $18.68 $93,400
Purchase
Common Stock 5,000 N/A N/A
Purchase
Common Stock 4,320 $11.13 $48,060
Purchase
Common Stock 4,320 $11.13 $48,060
Purchase
Common Stock 4,750 $10.91 $51,808

Mirum Pharmaceuticals key executives

Mirum Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: